How Catalyst Health Ventures Found a Sweet Spot in Early-Stage MedTech

Catalyst Health Ventures, led by Darshana Zaveri and Josh Phillips, is still writing early checks into unproven medical devices.

That stance stands out as medtech venture capital has shifted toward larger, later-stage rounds and fewer early-stage deals.

The article says patient-focused investors can help fund risky diagnostics and therapies before they are ready for bigger financing.

The broader takeaway: early-stage medtech still needs capital, even if exits take longer and the path to market is more uncertain.